Menu

CME Corner

Active Programs

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on August 20, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 milli ...

  • Online Presentation Online Presentation
  • ACCME
  • ANCC

Updating Clinical Practice in Rheumatoid Arthritis: Nursing Interventions to Promote Optimal Care

Patients with RA require ongoing management to maintain tight control of their RA disease activity and to reduce the risk of joint destruction, impaired physical functioning, and diminished quality of life. Comprehensive care of the RA patient also includes strategies to increase medication compliance and reduce the risk of CVD and other common comorbidities that can exacerbate the burden of RA. N ...

  • i-Newsletter i-Newsletter
  • ANCC

Advances in Multiple Sclerosis: Nursing Interventions to Promote Optimal Care

An estimated 350,000 to 500,000 people in the United States are currently diagnosed with MS, a chronic neurologic disorder with potential for substantial negative impact on quality of life. Nurses play an important role in addressing MS symptoms, managing adverse events, limiting disability, and coordinating with the collaborative care team to ensure that patients have the optimal treatment plan a ...

  • i-Newsletter i-Newsletter
  • ANCC

Advances in Multiple Sclerosis: Current Best Practices, Ongoing Challenges, and Future Directions

An estimated 350,000 to 500,000 people in the United States are currently diagnosed with MS, a chronic neurologic disorder with potential for substantial negative impact on quality of life. Treatment is focused on returning function after an attack, preventing new attacks, and preventing disability. The management of MS is increasingly challenging due to heterogeneity in the pathogenesis of MS, wi ...

  • Video Roundtable
  • ACCME
  • ANCC

Expired Programs

A Comprehensive Curriculum to Address Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Module 1: Assessing Patients for Treatment with ER/LA Opioid Analgesic Therapy

Opioid prescriptions have increased dramatically in the last decade, and opioid abuse and misuse has become a major public health concern. In 2012 the FDA approved a classwide risk management program, known as a Risk Evaluation and Mitigation Strategy (REMS), for all extended-release or long-acting (ER/LA) opioid analgesics. As part of this program, continuing education is being made available to ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

A Comprehensive Curriculum to Address Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Module 2: Initiating Therapy, Modifying Dosing, and Discontinuing Use of ER/LA Opioid Analgesics

Opioid prescriptions have increased dramatically in the last decade, and opioid abuse and misuse has become a major public health concern. In 2012 the FDA approved a classwide risk management program, known as a Risk Evaluation and Mitigation Strategy (REMS), for all extended-release or long-acting (ER/LA) opioid analgesics. As part of this program, continuing education is being made available to ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

A Comprehensive Curriculum to Address Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Module 3: Managing Therapy with ER/LA Opioid Analgesics

Opioid prescriptions have increased dramatically in the last decade, and opioid abuse and misuse has become a major public health concern. In 2012 the FDA approved a classwide risk management program, known as a Risk Evaluation and Mitigation Strategy (REMS), for all extended-release or long-acting (ER/LA) opioid analgesics. As part of this program, continuing education is being made available to ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

A Comprehensive Curriculum to Address Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Module 4: Counseling Patients and Caregivers about the Safe Use of ER/LA Opioid Analgesics

Opioid prescriptions have increased dramatically in the last decade, and opioid abuse and misuse has become a major public health concern. In 2012 the FDA approved a classwide risk management program, known as a Risk Evaluation and Mitigation Strategy (REMS), for all extended-release or long-acting (ER/LA) opioid analgesics. As part of this program, continuing education is being made available to ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

A Comprehensive Curriculum to Address Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Module 5: General Drug Information for ER/LA Opioid Analgesic Products

Opioid prescriptions have increased dramatically in the last decade, and opioid abuse and misuse has become a major public health concern. In 2012 the FDA approved a classwide risk management program, known as a Risk Evaluation and Mitigation Strategy (REMS), for all extended-release or long-acting (ER/LA) opioid analgesics. As part of this program, continuing education is being made available to ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

A Comprehensive Curriculum to Address Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Module 6: Specific Drug Information for ER/LA Opioid Analgesic Products

Opioid prescriptions have increased dramatically in the last decade, and opioid abuse and misuse has become a major public health concern. In 2012 the FDA approved a classwide risk management program, known as a Risk Evaluation and Mitigation Strategy (REMS), for all extended-release or long-acting (ER/LA) opioid analgesics. As part of this program, continuing education is being made available to ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Achieving Asthma Control: The Roles of Pharmacotherapy, Monitoring, Patient Education, and Environmental Control

Approximately 25 million Americans (8% of the population) suffer from asthma. Due to a variety of barriers, patients with asthma often do not have their asthma well controlled, leading to suboptimal patient outcomes. The CDC reports an estimated 13.9 million people with asthma experienced an asthma attack in the previous 12 months, a measure indicating suboptimal asthma control. With suboptimal as ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Achieving Better COPD Outcomes through Improved Assessment and Management Strategies

Chronic obstructive pulmonary disease (COPD) is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise tolerance, and chronic cough, usually with sputum production. In severe cases, there may be respiratory failure, right heart failure, or cachexia. In the United States, COPD affects more than ...

  • Online Presentation Online Presentation

Advancing the Management of AML: A 3-Part iNL Series
Issue 2: Targeted Therapies

A CME-certified interactive newsletter series on the management of acute myeloid leukemia (AML). Acute myeloid leukemia is a rapidly progressing cancer that starts in the bone marrow. AML can progress quickly without treatment; however, rates of remission and cure have increased over the past few decades as evidence for optimal therapeutic regimens has emerged. Cytogenetics and mutational gene ...

  • i-Newsletter i-Newsletter
  • ACCME

Advancing the Management of AML: A 3-Part iNL Series
Issue 3: Improving Outcomes for Older Patients Ineligible for Intensive Therapy

A CME-certified interactive newsletter series on the management of acute myeloid leukemia (AML). Acute myeloid leukemia is a rapidly progressing cancer that starts in the bone marrow. AML can progress quickly without treatment; however, rates of remission and cure have increased over the past few decades as evidence for optimal therapeutic regimens has emerged. Cytogenetics and mutational gene ...

  • i-Newsletter i-Newsletter
  • ACCME

An Update On Emerging Data on MS Treatment: Implications for Patient Care

MS is a chronic, often disabling disease that attacks the central nervous system (CNS), affecting an estimated 350,000 to 500,000 people in the US. The progress, severity, and specific symptoms of MS are unpredictable and vary from one person to another, with potential for substantial negative impact on quality of life. Due to the wide variation in the clinical course for each patient, it may not ...

  • Video Roundtable Video Roundtable
  • ACCME

An Update on the Role of Pregnancy in Multiple Sclerosis

An estimated 350,000 to 500,000 people in the United States are currently diagnosed with multiple sclerosis (MS), a chronic, neurologic disorder with potential for substantial negative impact on quality of life. Pregnancy is a major topic in patient counseling and therapeutic selection. Without a thorough understanding of data about MS and pregnancy, clinicians cannot appropriately educate their p ...

  • i-Newsletter i-Newsletter
  • ACCME

Chronic Constipation and Constipation-Predominant Irritable Bowel Syndrome: Fostering a Patient-Centric Model of Care

Constipation-predominant irritable bowel syndrome (IBS-C) is a subtype of IBS that comprises approximately 20% of IBS cases and is associated with poor health-related quality of life. Chronic constipation (CC) affects approximately 15% of US adults (with a prevalence as high as 34% in older adults) and is associated with a similarly negative impact on quality of life. Adequate treatment of IBS-C a ...

  • Online Presentation Online Presentation
  • ACCME

Clinical Challenges and Opportunities in the Management of Major Depressive Disorder (MDD)

NOTE: This activity was presented as a live visiting faculty grand rounds series on 17 occasions between January 29, 2014 and June 26, 2014. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Numerous treatments are available for the management of MDD, yet many patients do not obtain relief from their symptom ...

  • Online Presentation Online Presentation
  • ACCME

Clinical Challenges and Opportunities in the Management of Overactive Bladder
Hope for Improved Symptom Control: Evidence-based Treatment Approaches for OAB

Overactive bladder (OAB) is the most common cause of urinary incontinence or loss of bladder control in adults and affects 30% to 60% of older women and 10% to 35% of older men in the United States. The symptoms of OAB often lead to additional medical and psychological problems and can have a detrimental impact on quality of life. Due to a variety of barriers, however, OAB is underdiagnosed and un ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Clinical Challenges and Opportunities in the Management of Overactive Bladder
No Need to Suffer in Silence: Identifying and Diagnosing OAB

Overactive bladder (OAB) is the most common cause of urinary incontinence or loss of bladder control in adults and affects 30% to 60% of older women and 10% to 35% of older men in the United States. The symptoms of OAB often lead to additional medical and psychological problems and can have a detrimental impact on quality of life. Due to a variety of barriers, however, OAB is underdiagnosed and un ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Clinical Insights in Pediatrics: A Clinical Overview of Food Allergies in Infants and Children

Food allergy is an immune-based disease that has increased in the US in recent years according to several national health surveys. The prevalence of reported food allergy increased 18% from 1997 to 2007, and it is now estimated to affect 5% of children under the age of 5 years. Food allergy occurs most often in the first 3 years of life. The most common food allergens are eggs, milk, peanuts, tree ...

  • i-Newsletter i-Newsletter
  • NAPNAP

Clinical Insights in Pediatrics: Comprehensive Care in Pediatric Inflammatory Bowel Disease

The challenges associated with the diagnosis and differentiation of pediatric IBD are numerous and include varying clinical presentations and appropriate diagnostic modalities. Treatment is often impeded by a lack of clinical trial data on which to develop guidelines, as well as a lack of consideration of pediatric-specific issues. Likewise, there are myriad management issues surrounding pediatric ...

  • i-Newsletter i-Newsletter
  • NAPNAP

Clinical Insights into the Optimal Management of COPD

Chronic obstructive pulmonary disease (COPD) is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise tolerance, chronic cough with or without sputum production, wheezing, and respiratory failure or right heart failure. In the United States, COPD affects more than 5% of the adult population a ...

  • Online Presentation Online Presentation
  • ACCME

Collaborative Care: A Team Approach to Managing Patients with MS

An estimated 350,000 to 500,000 people in the United States are currently diagnosed with multiple sclerosis (MS), a chronic neurologic disorder with potential for substantial negative impact on quality of life. While MS is managed primarily by neurologists, primary care physicians (PCPs) must be able to recognize signs and symptoms that may be suggestive of, or related to, MS so that they can make ...

  • Video Roundtable Video Roundtable
  • AAPA
  • ACCME
  • ANCC

Emerging Data to Improve Patient Management

MS is a chronic, often disabling disease that attacks the central nervous system (CNS), affecting an estimated 350,000 to 500,000 people in the US. The progress, severity, and specific symptoms of MS are unpredictable and vary from one person to another, with potential for substantial negative impact on quality of life. Due to the wide variation in the clinical course for each patient, it may not ...

  • Video Roundtable Video Roundtable

Improving Stroke Prevention in Atrial Fibrillation: The New Oral Anticoagulants

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on May 23, 2014. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Clinicians have the opportunity to reduce the risk of stroke in patients with atrial fibrillation (AF) by appropriately assessing patients’ risk for st ...

  • Online Presentation Online Presentation
  • ACCME

Improving the Treatment of Major Depressive Disorder in Older Adults: Clinical Advances and Emerging Therapies

A CPE-certified online interactive newsletter with highlights from the American Society of Consultant Pharmacists workshop. An estimated 6.5 million (about 19%) of older adults in the United States suffer from major depressive disorder (MDD), a condition that leads to significant disability and medical comorbidity. In the long-term care setting, up to 35% of older adults suffer from depression ...

  • i-Newsletter i-Newsletter
  • ACPE

Molecular Testing in NSCLC: A Strategic QI Initiative
Video Roundtable Discussion

This roundtable discussion features key participants in a quality improvement initiative to improve rates of molecular testing in NSCLC at Albert Einstein College of Medicine of Yeshiva University/Montefiore Medical Center. The discussion provides background information about the clinical significance of NSCLC molecular testing, reviews baseline data on Montefiore/Einstein molecular testing in NSC ...

  • Video Roundtable Video Roundtable
  • ACCME

New Insights in Psoriatic Arthritis Treatment

The goal of this continuing medical education activity is to increase the ability of rheumatologists to integrate best practices based on the latest clinical evidence for the treatment of psoriatic arthritis (PsA), ultimately improving quality of life and reducing complications for these patients. ...

  • i-Newsletter i-Newsletter
  • ACCME

Optimizing Anticoagulation Therapy for Older Adults with Atrial Fibrillation: The New Oral Agents

A CPE-certified online interactive newsletter with highlights from the American Society of Consultant Pharmacists workshop. Although current evidence shows most strokes related to atrial fibrillation (AF) can be prevented with anticoagulation therapy, many older adults with AF are not receiving optimal therapy. Senior care pharmacists have the opportunity to reduce the risk of stroke in patien ...

  • i-Newsletter i-Newsletter
  • ACPE

Optimizing Glycemic Control and Avoiding Hypoglycemia in Older Adults With Type 2 Diabetes

The live version of this activity took place on November 8, 2012 in National Harbor, MD. If you attended and received credit for the live event you may NOT receive credit for this archived event. The prevalence of type 2 diabetes mellitus (T2DM) has reached an epidemic level and continues to rise. The American Diabetes Association (ADA) estimates that 25.8 million people, approximately 8.3% of ...

  • Link - Online Link - Online
  • ACPE

Optimizing the Management of COPD Among Primary Care Clinicians

Chronic obstructive pulmonary disease (COPD) is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise tolerance, chronic cough with or without sputum production, wheezing, and respiratory failure or right heart failure. In the United States, COPD affects more than 5% of the adult population a ...

  • Online Presentation Online Presentation
  • ACCME

Optimizing the Medical Management of IBD by Primary Care Clinicians

Ulcerative colitis (UC) and Crohn’s disease (CD), which together are referred to as inflammatory bowel disease (IBD), are complex conditions. Because of the complicated nature of IBD, diagnosis and treatment is impeded by numerous obstacles that can affect diagnostic accuracy and quality of care. In addition, new data available to clinicians are revising the management paradigm for IBD. These new ...

  • Online Presentation Online Presentation

Optimizing the Use of Biologics for Moderate to Severe Plaque Psoriasis

Psoriasis is a multisystem, immune-mediated, inflammatory disease, manifesting as chronic inflammation of the skin as well as joints in a subgroup of patients. Approximately 2% to 3% of the US population (an estimated 7.5 million Americans) has psoriasis. Plaque psoriasis, the most common form, affects 80% to 90% of individuals with psoriasis. Moderate to severe plaque psoriasis is often disfiguri ...

  • i-Newsletter i-Newsletter
  • ACCME

Overcoming Barriers to Successful Asthma Control

Approximately 25 million Americans (8% of the population) suffer from asthma. Due to a variety of barriers, patients with asthma often do not have their asthma well controlled, leading to suboptimal patient outcomes. Greater efforts are needed in the management of asthma to help patients achieve asthma control. With better control, patients with asthma will experience less suffering from asthma sy ...

  • Online Presentation Online Presentation
  • ACCME

Overcoming Barriers to Successful Asthma Control: Ask the Experts

Approximately 25 million Americans (8% of the population) suffer from asthma. Due to a variety of barriers, patients with asthma often do not have their asthma well controlled, leading to suboptimal patient outcomes. Greater efforts are needed in the management of asthma to help patients achieve asthma control. With better control, patients with asthma will experience less suffering from asthma sy ...

  • Online Presentation Online Presentation
  • ACCME

Practical Tips for Using Oral Agents for MS

An estimated 350,000 to 500,000 people in the United States are currently diagnosed with multiple sclerosis (MS), a chronic, neurologic disorder with potential for substantial negative impact on quality of life. A wide variety of neurological symptoms can occur with MS, including tingling and numbness, loss of balance, weakness in one or more limbs, and vision problems. Treatment is focused on ret ...

  • i-Newsletter i-Newsletter
  • ACCME

Prioritizing Interventions in Older Adults with Type 2 Diabetes

A CPE-certified online monograph with highlights from the American Society of Consultant Pharmacists workshop. The prevalence of type 2 diabetes mellitus (T2DM) has reached epidemic levels and continues to rise. The American Diabetes Association (ADA) estimates that 25.8 million people, approximately 8.3% of the U.S. population, have diabetes. In the older adult population, the prevalence of d ...

  • e-Monograph e-Monograph
  • ACPE

Targeting Molecular Abnormalities in NSCLC

THIS PROGRAM WAS ORIGINALLY PRESENTED AS A VISITING FACULTY GRAND ROUNDS SERIES THROUGHOUT THE COUNTRY, BEGINNING ON AUGUST 12, 2014. IF YOU HAVE ALREADY RECEIVED CREDIT FOR ATTENDING ONE OF THE LIVE MEETINGS, YOU ARE INELIGIBLE TO RECEIVE CREDIT FOR THIS ENDURING ACTIVITY. Lung cancer is the leading cause of cancer death in the United States. Non-small cell lung cancer (NSCLC) is the most comm ...

  • Online Presentation Online Presentation
  • ACCME

The Latest Research and Treatment Recommendations for Newly Diagnosed Multiple Myeloma

New evidence on optimal treatment approaches for patients with multiple myeloma (MM) is emerging at a rapid pace. Hematology and oncology clinicians are not fully prepared to incorporate emerging investigational therapies into treatment plans for patients with MM. Clinicians have the opportunity to improve outcomes in patients with MM by keeping abreast of evolving clinical practice guidelines to ...

  • Video Roundtable Video Roundtable
  • ACCME

The Latest Research and Treatment Recommendations for Progressive or Relapsed Multiple Myeloma

New evidence on optimal treatment approaches for patients with multiple myeloma (MM) is emerging at a rapid pace. Hematology and oncology clinicians are not fully prepared to incorporate emerging investigational therapies into treatment plans for patients with MM. Clinicians have the opportunity to improve outcomes in patients with MM by keeping abreast of evolving clinical practice guidelines to ...

  • Video Roundtable Video Roundtable
  • ACCME

The Substance Use SBIRTmentorTM

Welcome to the Substance Use SBIRTmentor™! Like you, we understand that disease prevention and the reduction of harm related to substance use are integral to the practice of nursing – and that screening, brief intervention, and referral to treatment (SBIRT) of patients for substance use is becoming a critical part of today’s patient care. With the Substance Use SBIRTmentor™ program, you will ...

  • Online Presentation Online Presentation

Ulcerative Colitis i-Newsletter Series
Issue 1, August 2013
Ulcerative Colitis: Considering Treatment Goals and Patient Prognosis

A CME-certified interactive newsletter series on the recognition, diagnosis, and treatment of ulcerative colitis (UC). UC is a chronic condition with substantial morbidity, including debilitating symptoms, frequent need of high-risk procedures such as surgery, and decreased health-related quality of life. The medical management of UC has changed significantly in recent years due to progress in ...

  • i-Newsletter i-Newsletter
  • ACCME

Ulcerative Colitis i-Newsletter Series
Issue 2, September 2013
Safety and Efficacy of Biologic Therapies in UC

A CME-certified interactive newsletter series on the recognition, diagnosis, and treatment of ulcerative colitis (UC). UC is a chronic condition with substantial morbidity, including debilitating symptoms, frequent need of high-risk procedures such as surgery, and decreased health-related quality of life. The medical management of UC has changed significantly in recent years due to progress in ...

  • i-Newsletter i-Newsletter
  • ACCME

Ulcerative Colitis i-Newsletter Series
Issue 3, February 2014
Current and Emerging Management Strategies for the Treatment of UC

A CME-certified interactive newsletter series on the recognition, diagnosis, and treatment of ulcerative colitis (UC). UC is a chronic condition with substantial morbidity, including debilitating symptoms, frequent need of high-risk procedures such as surgery, and decreased health-related quality of life. The medical management of UC has changed significantly in recent years due to progress in ...

  • i-Newsletter i-Newsletter
  • ACCME

Update on Hypertriglyceridemia: Clinical Relevance and Treatment Recommendations

This educational activity will provide an overview of hypertriglyceridemia, with a focus on: • Lipoprotein metabolism, including TRLs and remnant cholesterol • Risks of triglyceride elevation, including pancreatitis and atherosclerotic CVD • Genetic and secondary causes of triglyceride elevation • Lifestyle and pharmacologic strategies directed toward clinical management of patients with high ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Updating Clinical Practice in Rheumatoid Arthritis: New Approaches for Optimal Care

The goal of this expert roundtable discussion is to expand the ability of rheumatology clinicians to implement best practices in the management of RA based on the latest clinical evidence. RA currently affects approximately 1.3 million people in the United States. Without early treatment that emphasizes tight control of disease activity, RA progresses to cause joint destruction, decreased physical ...

  • Video Roundtable Video Roundtable
  • ACCME
  • ANCC

Webconference On Demand: MS Experts Discuss Your Questions

THIS ACTIVITY WAS ORIGINALLY PRESENTED AS A LIVE WEBCONFERENCE ON JULY 16, 2014. IF YOU RECEIVED CREDIT FOR PARTICIPATING IN THE LIVE EVENT, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ENDURING ARCHIVE. An estimated 350,000 to 500,000 people in the United States are currently diagnosed with multiple sclerosis (MS), a chronic neurologic disorder with potential for substantial negative impac ...

  • Online Presentation
  • ACCME
Advertisement
Advertisement
Main Menu
EDITOR'S PICKS